Investigating how mitochondrial DNA stress affects immune responses
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
This study is looking at how stress on the tiny energy factories in our cells, called mitochondria, can affect our immune system and possibly lead to diseases like autoimmune disorders, with the hope of finding new ways to help patients feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11076348 on NIH RePORTER |
What this research studies
This research explores the relationship between mitochondrial DNA (mtDNA) stress and the immune system. It focuses on how damage to mtDNA can trigger abnormal immune responses, which may contribute to various diseases, including autoimmune disorders and neuroinflammation. By identifying the mechanisms and triggers of this process, the research aims to uncover new therapeutic targets for improving patient outcomes. Patients may benefit from insights that could lead to novel treatments for conditions linked to mitochondrial dysfunction.
Who could benefit from this research
Good fit: Ideal candidates include individuals with autoimmune conditions or those undergoing cancer treatment who may benefit from enhanced immune responses.
Not a fit: Patients with conditions unrelated to mitochondrial dysfunction or immune response abnormalities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for autoimmune diseases and improve cancer treatment strategies.
How similar studies have performed: Previous research has shown promising results in understanding mitochondrial roles in immunity, suggesting potential for breakthroughs in this area.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Tigano, Marco — Thomas Jefferson University
- Study coordinator: Tigano, Marco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.